Cargando…
Differential Levels of Soluble Inflammatory Markers by Human Immunodeficiency Virus Controller Status and Demographics
Background. Human immunodeficiency virus (HIV)-1 elite controllers (ECs) represent an ideal population to study the effects of HIV persistence on chronic inflammation in the absence of antiretroviral therapy (ART). Methods. Twenty inflammatory markers measured in cohorts of ECs, HIV suppressed nonco...
Autores principales: | Li, Jonathan Z., Arnold, Kelly B., Lo, Janet, Dugast, Anne-Sophie, Plants, Jill, Ribaudo, Heather J., Cesa, Kevin, Heisey, Andrea, Kuritzkes, Daniel R., Lauffenburger, Douglas A., Alter, Galit, Landay, Alan, Grinspoon, Steven, Pereyra, Florencia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396431/ https://www.ncbi.nlm.nih.gov/pubmed/25884005 http://dx.doi.org/10.1093/ofid/ofu117 |
Ejemplares similares
-
Assessment of Obesity and Cardiometabolic Status by Integrase Inhibitor Use in REPRIEVE: A Propensity-Weighted Analysis of a Multinational Primary Cardiovascular Prevention Cohort of People With Human Immunodeficiency Virus
por: Kileel, Emma M, et al.
Publicado: (2021) -
Genome-Wide Association Study of Human Immunodeficiency Virus (HIV)-1 Coreceptor Usage in Treatment-Naive Patients from An AIDS Clinical Trials Group Study
por: Henrich, Timothy J., et al.
Publicado: (2014) -
Aspartame Intake Relates to Coronary Plaque Burden and Inflammatory Indices in Human Immunodeficiency Virus
por: Hall, Leangelo N., et al.
Publicado: (2017) -
Aspirin Use for Primary and Secondary Prevention in Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Patients
por: Suchindran, Sujit, et al.
Publicado: (2014) -
Sex Differences in Subclinical Atherosclerosis and Systemic Immune Activation/Inflammation Among People With Human Immunodeficiency Virus in the United States
por: Zanni, Markella V, et al.
Publicado: (2022)